Merck Serono to invest $130+ million in biosimilars


(Photo Courtesy:

Hinging on the results of its Phase I studies, Merck Serono plans to invest more than $130 million in biosimilars in 2015.

This is in addition to its previous investment in biosimilar worth €100 million this year.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email